Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Karrie Ly

Physician Assistant Stockton, CA Physician Assistant

NPI 1598383382 CMS profile 10460412

1800 N California St, Stockton, CA 95204

Open in the dashboard

General payments

$4,436

127 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Karrie Ly of Stockton, CA is reported in the CMS Open Payments database as having received $4,436 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $988 59
2024 General $1,360 23
2023 General $354 15
2022 General $1,572 20
2021 General $162 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karrie Ly
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Karrie Ly were reported at $988. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Karrie Ly Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $162 $132 $37–$438 $132
2022 $1,572 $155 $48–$522 $149
2023 $354 $167 $52–$557 $160
2024 $1,360 $178 $55–$600 $164
2025 $988 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,346 17 payments
  2. Boston Scientific Corporation $1,217 52 payments
  3. Inari Medical, Inc. $956 6 payments
  4. Stryker Corporation $551 36 payments
  5. Shockwave Medical, Inc $191 9 payments
  6. Bioprotect Medical, Inc. $98 1 payment
  7. Terumo Medical Corporation $61 4 payments
  8. Sirtex Medical Inc $16 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,963 120 payments
  2. Travel and Lodging $1,473 7 payments
Products named General payments · program years 2021–2025
  1. VENASEAL $1,245 12 payments
  2. CT THROMBECTOMY SYSTEM KIT $979 7 payments
  3. FLOWTRIEVER CATHETER, S $979 7 payments
  4. TheraSphere Y90 Glass Microspheres 10 GBq $448 11 payments
  5. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $376 19 payments
  6. ARTIX MT $229 8 payments
  7. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $174 8 payments
  8. EMBOLD Fibered $138 8 payments
  9. CLOTTRIEVER BOLD CATHETER $105 11 payments
  10. INTHRILL THROMBECTOMY CATHETER $103 9 payments
  11. Other $623 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

113

Median for Physician Assistant: 241

Drug cost

$419

Median for Physician Assistant: $4,110

Branded share of claims

33.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 18 $166
Methylprednisolone Generic 20 $100
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 20 $52
Ciprofloxacin Hcl Generic 26 $48
Omeprazole Generic 12 $40
Lorazepam Generic 17 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$22,904

Medicare's payments for the services billed

Medicare patients

201

Average age 74

Services billed

311

89 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 55%
Diabetes 54%
Heart failure 51%
Ischemic heart disease 48%
Atrial fibrillation 41%
Arthritis 36%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record